Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Lymphoid 1

Conditions

Lymphoma 26Precursor Cell Lymphoblastic Leukemia-Lymphoma 21Leukemia 17Lymphoma, Non-Hodgkin 16Sarcoma 9Leukemia, Myeloid, Acute 9Hodgkin Disease 9Hematologic Neoplasms 9Neuroblastoma 8Neoplasms 8Myelodysplastic Syndromes 7Leukemia, Lymphocytic, Chronic, B-Cell 7Leukemia, Myelogenous, Chronic, BCR-ABL Positive 6Burkitt Lymphoma 6Osteosarcoma 5Melanoma 5Lymphoma, Mantle-Cell 5Lymphoma, Follicular 5Breast Neoplasms 5Rhabdoid Tumor 4Retinoblastoma 4Multiple Myeloma 4Medulloblastoma 4Lymphoma, Large B-Cell, Diffuse 4Wilms Tumor 3Recurrence 3Neoplasms, Germ Cell and Embryonal 3Myeloproliferative Disorders 3Hepatoblastoma 3Graft vs Host Disease 3

Interventions

Cyclophosphamide 77Dexamethasone 74Melphalan 65Lenalidomide 50Bortezomib 50Peripheral Blood Stem Cell Transplantation 49fludarabine phosphate 47Busulfan 46Filgrastim 39Tacrolimus 37Antilymphocyte Serum 33Radiotherapy 30Mycophenolic Acid 30Thalidomide 28fludarabine 24Methotrexate 22Whole-Body Irradiation 21Cyclosporine 21Calcium Dobesilate 21Granulocyte Colony-Stimulating Factor 18Methylprednisolone 17Etoposide 17Cord Blood Stem Cell Transplantation 14daratumumab 11Prednisone 11Carmustine 11sargramostim 10Stem Cell Transplantation 10Sirolimus 10Rituximab 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Neoplasms, Plasma Cell × Mesna × Clear all
NCT00473551 2011-12-19

Anti-Third Party T Lymphocytes With Nonmyeloablative Stem Cell Transplantation for Indolent Lymphoid Malignancies

M.D. Anderson Cancer Center

Phase 1 Terminated
4 enrolled
LymphoidOther hematologic neoplasmPlasma cell

Graft vs Host Disease, Leukemia, Lymphoma, Leukemia, Lymphocytic, Chronic, B-Cell, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡